Revvity (NYSE:RVTY) Rating Lowered to Strong Sell at Zacks Research

Revvity (NYSE:RVTY) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Monday,Zacks.com reports.

Several other analysts also recently weighed in on the stock. Weiss Ratings raised shares of Revvity from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Wolfe Research began coverage on shares of Revvity in a research report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Barclays boosted their target price on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, JPMorgan Chase & Co. cut their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Four analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $108.92.

Revvity Stock Down 0.7%

RVTY opened at $112.15 on Monday. Revvity has a 52 week low of $81.22 and a 52 week high of $118.30. The business has a 50 day moving average price of $100.42 and a two-hundred day moving average price of $98.36. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. The company has a market cap of $12.51 billion, a PE ratio of 53.66, a P/E/G ratio of 2.47 and a beta of 1.09.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The business had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, research analysts anticipate that Revvity will post 5.25 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Ascentis Independent Advisors purchased a new stake in Revvity in the 1st quarter valued at approximately $29,000. CYBER HORNET ETFs LLC purchased a new position in Revvity during the second quarter worth $32,000. Cromwell Holdings LLC raised its holdings in shares of Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after acquiring an additional 198 shares during the last quarter. MUFG Securities EMEA plc purchased a new stake in shares of Revvity in the second quarter valued at $34,000. Finally, SJS Investment Consulting Inc. lifted its position in shares of Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock valued at $47,000 after acquiring an additional 521 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.